Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fever

Coding Corner Question: August Coding Challenge

Staff  |  August 8, 2012

A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:anti-inflammatoryBillingCodingdrugimaginginfliximabPractice ManagementRheumatoid arthritisrheumatologist

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD  |  July 10, 2012

Treatment options and recent research for juvenile dermatomyositis.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ANA titerdrugHYDROXYCHLOROQUINEinflammationinflammatory myopathyintravenous immune globulinjuvenile dermatomyositisMethotrexatepatient carePediatricsrheumatologistrituximab

Advocating for Rheumatology: A Patient’s Perspective

Tami Brown  |  June 10, 2012

I have made it my personal goal to ensure that future patients don’t have to go through the same uncertainty and delayed treatment that I went through.

Filed under:From the CollegeLegislation & AdvocacyProfessional TopicsProfiles Tagged with:AC&RAdvocacyAdvocating with YouAmerican College of Rheumatology (ACR)ProfileRheumatoid arthritisrheumatologist

Coding Corner: Incident-To

Staff  |  June 10, 2012

A 65-year-old female Medicare patient with rheumatoid arthritis sees a nonphysician provider for a followup visit.

Filed under:Billing/CodingPractice Support Tagged with:anti-inflammatoryBillingCodingincident-toMethotrexateNPPPractice ManagementRheumatoid arthritis

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

Patient Fact Sheet: Juvenile Idiopathic Arthritis

Staff  |  May 9, 2012

Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.

Filed under:Career DevelopmentConditionsEducation & TrainingFrom the CollegeProfessional TopicsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)inflammationJIAJuvenile idiopathic arthritispatient carepatient educationPediatricsPsoriatic ArthritisRheumatoid arthritisrheumatologist

Coding Corner: May’s Coding Challenge

Staff  |  May 9, 2012

A 54-year-old female with rheumatoid arthritis is seen by the rheumatologist for a follow-up visit.

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:BillingCodingdrugimaginglabsMedicareMethotrexateprednisoneRheumatoid arthritisrheumatologist

Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis

Eli Miloslavsky, MD  |  May 8, 2012

A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.

Filed under:ConditionsVasculitis Tagged with:ANCAANCA-Associated VasculitisDiagnosisdrugGlucocorticoidsgranulomatosis with polyangiitishematuriaimagingrheumatologistrituximabTreatmentVasculitisvisual loss

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD  |  March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:anti-inflammatorydrugHYDROXYCHLOROQUINEimmunodeficiencyinflammationintravenous immune globulinMethotrexatemyalgiapatient carePediatricsrheumatologistTreatment

Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability

Candace H. Feldman, MD, MPH, Gwendolyn Kane-Wagner, MD  |  March 8, 2012

A 49-year-old man presented to the hospital with confusion, dysarthria, expressive aphasia, and progressive gait instability.

Filed under:Career DevelopmentConditionsEducation & TrainingOther Rheumatic ConditionsProfessional Topics Tagged with:ANA titerDiagnostic Criteriadrugimagingintravenous immunoglobulinsPathogenesispatient careprednisonerheumatologistTreatment

  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 54
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences